BCL6 and metabolic dysfunction-associated steatohepatitis: These results suggested that the signalling pathway repressing NASH-induced liver tumours in male Bcl6-LKO mice is regulated by the repression of IL6 production and Bcl6-related mechanisms regulating gender-different liver functional genes.